View in EDS HTML Full Text PDF Full Text

Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study.

Saved in:
Bibliographic Details
Title: Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study.
Authors: Puri A; Hammersmith Medicines Research Limited, Cumberland Avenue, London NW10 7EW, UK., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Centre for Clinical Vaccinology and Tropical Medicine (CCVTM), and NIHR Oxford Biomedical Research Centre, Churchill Hospital, Old Road, Headington, Oxford OX3 7LE, UK., Schmidt-Mutter C; Inserm CIC 1434, CHU Strasbourg, 1 Place de l'Hôpital, 67091 Strasbourg, France., Lainé F; Inserm CIC 1414, CHU Rennes, Rue Henri Le Guillou, 35033 Rennes, France., PrayGod G; Mwanza Research Center, National Institute for Medical Research, Isamilo Road, Mwanza P.O. Box 1462, Tanzania., Kibuuka H; Makerere University Walter Reed Project, Plot 42 Nakasero Road, Kampala P.O. Box 16524, Uganda., Barry H; Centre MURAZ, 2054 Avenue Mamadou Konaté, Bobo Dioulasso 01 BP 390, Burkina Faso., Nicolas JF; Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, Université Claude Bernard Lyon I, 69364 Lyon, France., Lelièvre JD; INSERM U955, Vaccine Research Institute, CHU Henri Mondor 1 rue Gustave Eiffel, 94000 Créteil, France., Sirima SB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou 06 BP 10248, Burkina Faso., Kamala B; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza P.O. Box 11936, Tanzania., Manno D; Department of Clinical Research, London School of Hygiene and Tropical Medicine, Keppel St, London WC1E 7HT, UK., Watson-Jones D; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza P.O. Box 11936, Tanzania.; Department of Clinical Research, London School of Hygiene and Tropical Medicine, Keppel St, London WC1E 7HT, UK., Gaddah A; Janssen Research & Development, Turnhoutseweg 30, B-2340 Beerse, Belgium., Keshinro B; Janssen Vaccines & Prevention B.V., Archimedesweg 6, 2333 CN Leiden, The Netherlands., Luhn K; Janssen Vaccines & Prevention B.V., Archimedesweg 6, 2333 CN Leiden, The Netherlands., Robinson C; Janssen Vaccines & Prevention B.V., Archimedesweg 6, 2333 CN Leiden, The Netherlands., Douoguih M; Janssen Vaccines & Prevention B.V., Archimedesweg 6, 2333 CN Leiden, The Netherlands.
Corporate Authors: EBL4001 Study Group
Source: Vaccines [Vaccines (Basel)] 2024 Feb 17; Vol. 12 (2). Date of Electronic Publication: 2024 Feb 17.
Publication Type: Journal Article
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38400193
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Puri+A%22">Puri A</searchLink>; Hammersmith Medicines Research Limited, Cumberland Avenue, London NW10 7EW, UK.<br /><searchLink fieldCode="AU" term="%22Pollard+AJ%22">Pollard AJ</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Centre for Clinical Vaccinology and Tropical Medicine (CCVTM), and NIHR Oxford Biomedical Research Centre, Churchill Hospital, Old Road, Headington, Oxford OX3 7LE, UK.<br /><searchLink fieldCode="AU" term="%22Schmidt-Mutter+C%22">Schmidt-Mutter C</searchLink>; Inserm CIC 1434, CHU Strasbourg, 1 Place de l'Hôpital, 67091 Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Lainé+F%22">Lainé F</searchLink>; Inserm CIC 1414, CHU Rennes, Rue Henri Le Guillou, 35033 Rennes, France.<br /><searchLink fieldCode="AU" term="%22PrayGod+G%22">PrayGod G</searchLink>; Mwanza Research Center, National Institute for Medical Research, Isamilo Road, Mwanza P.O. Box 1462, Tanzania.<br /><searchLink fieldCode="AU" term="%22Kibuuka+H%22">Kibuuka H</searchLink>; Makerere University Walter Reed Project, Plot 42 Nakasero Road, Kampala P.O. Box 16524, Uganda.<br /><searchLink fieldCode="AU" term="%22Barry+H%22">Barry H</searchLink>; Centre MURAZ, 2054 Avenue Mamadou Konaté, Bobo Dioulasso 01 BP 390, Burkina Faso.<br /><searchLink fieldCode="AU" term="%22Nicolas+JF%22">Nicolas JF</searchLink>; Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, Université Claude Bernard Lyon I, 69364 Lyon, France.<br /><searchLink fieldCode="AU" term="%22Lelièvre+JD%22">Lelièvre JD</searchLink>; INSERM U955, Vaccine Research Institute, CHU Henri Mondor 1 rue Gustave Eiffel, 94000 Créteil, France.<br /><searchLink fieldCode="AU" term="%22Sirima+SB%22">Sirima SB</searchLink>; Groupe de Recherche Action en Santé (GRAS), Ouagadougou 06 BP 10248, Burkina Faso.<br /><searchLink fieldCode="AU" term="%22Kamala+B%22">Kamala B</searchLink>; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza P.O. Box 11936, Tanzania.<br /><searchLink fieldCode="AU" term="%22Manno+D%22">Manno D</searchLink>; Department of Clinical Research, London School of Hygiene and Tropical Medicine, Keppel St, London WC1E 7HT, UK.<br /><searchLink fieldCode="AU" term="%22Watson-Jones+D%22">Watson-Jones D</searchLink>; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza P.O. Box 11936, Tanzania.; Department of Clinical Research, London School of Hygiene and Tropical Medicine, Keppel St, London WC1E 7HT, UK.<br /><searchLink fieldCode="AU" term="%22Gaddah+A%22">Gaddah A</searchLink>; Janssen Research & Development, Turnhoutseweg 30, B-2340 Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Keshinro+B%22">Keshinro B</searchLink>; Janssen Vaccines & Prevention B.V., Archimedesweg 6, 2333 CN Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Luhn+K%22">Luhn K</searchLink>; Janssen Vaccines & Prevention B.V., Archimedesweg 6, 2333 CN Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Robinson+C%22">Robinson C</searchLink>; Janssen Vaccines & Prevention B.V., Archimedesweg 6, 2333 CN Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Douoguih+M%22">Douoguih M</searchLink>; Janssen Vaccines & Prevention B.V., Archimedesweg 6, 2333 CN Leiden, The Netherlands.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22EBL4001+Study+Group%22">EBL4001 Study Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101629355%22">Vaccines</searchLink> [Vaccines (Basel)] 2024 Feb 17; Vol. 12 (2). <i>Date of Electronic Publication: </i>2024 Feb 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI+AG%22">MDPI AG </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101629355 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2076-393X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222076393X%22">2076393X </searchLink><i>NLM ISO Abbreviation: </i>Vaccines (Basel) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38400193
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/vaccines12020210
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Puri A
      – PersonEntity:
          Name:
            NameFull: Pollard AJ
      – PersonEntity:
          Name:
            NameFull: Schmidt-Mutter C
      – PersonEntity:
          Name:
            NameFull: Lainé F
      – PersonEntity:
          Name:
            NameFull: PrayGod G
      – PersonEntity:
          Name:
            NameFull: Kibuuka H
      – PersonEntity:
          Name:
            NameFull: Barry H
      – PersonEntity:
          Name:
            NameFull: Nicolas JF
      – PersonEntity:
          Name:
            NameFull: Lelièvre JD
      – PersonEntity:
          Name:
            NameFull: Sirima SB
      – PersonEntity:
          Name:
            NameFull: Kamala B
      – PersonEntity:
          Name:
            NameFull: Manno D
      – PersonEntity:
          Name:
            NameFull: Watson-Jones D
      – PersonEntity:
          Name:
            NameFull: Gaddah A
      – PersonEntity:
          Name:
            NameFull: Keshinro B
      – PersonEntity:
          Name:
            NameFull: Luhn K
      – PersonEntity:
          Name:
            NameFull: Robinson C
      – PersonEntity:
          Name:
            NameFull: Douoguih M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 17
              M: 02
              Text: 2024 Feb 17
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 2076-393X
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Vaccines
              Type: main
ResultId 1